최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Theranostics, v.5 no.7, 2015년, pp.746 - 754
Saw, Phei Er (1. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and technology (KAIST), 291 Daehak-ro, Daejeon 305-701, Republic of Korea.) , Park, Jinho (1. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and technology (KAIST), 291 Daehak-ro, Daejeon 305-701, Republic of Korea.) , Lee, Eunbeol (1. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and technology (KAIST), 291 Daehak-ro, Daejeon 305-701, Republic of Korea.) , Ahn, Sukyung (1. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and technology (KAIST), 291 Daehak-ro, Daejeon 305-701, Republic of Korea.) , Lee, Jinju (3. School of Life Sciences, Gwangju Institute of Science and Technology, 123-Cheomdangwagi-ro, Gwangju 500-712, Republic of Korea.) , Kim, Hyungjun (1. KAIST Institute for the BioCentury, Department of Biological Sciences, Korea Advanced Institute of Science and techn) , Kim, Jinjoo , Choi, Minsuk , Farokhzad, Omid C. , Jon, Sangyong
Standardized poly(ethylene glycol)-modified (PEGylated) liposomes, which have been widely used in research as well as in pre-clinical and clinical studies, are typically constructed using PEG with a molecular weight of 2000 Da (PEG2000). Targeting ligands are also generally conjugated using various ...
1 Barenholz Y Doxil(R)--the first FDA-approved nano-drug: lessons learned J Control Release 2012 160 117 34 22484195
2 Luk BT Fang RH Zhang L Lipid- and polymer-based nanostructures for cancer theranostics Theranostics 2012 2 1117 26 23382770
3 Malam Y Loizidou M Seifalian AM Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol Sci 2009 30 592 9 19837467
4 Allen TM Cheng WW Hare JI Laginha KM Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer Anticancer Agents Med Chem 2006 6 513 23 17100556
5 Sapra P Tyagi P Allen TM Ligand-targeted liposomes for cancer treatment Curr Drug Deliv 2005 2 369 81 16305440
6 Immordino ML Dosio F Cattel L Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int J Nanomedicine 2006 1 297 315 17717971
7 Allen TM Liposomal drug formulations - Rationale for development and what we can expect for the future Drugs 1998 56 747 56 9829150
8 Lasic DD Martin FJ Gabizon A Huang SK Papahadjopoulos D Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times Biochim Biophys Acta 1991 1070 187 92 1751525
9 Gabizon AA Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet Clin Cancer Res 2001 7 223 5 11234871
10 Allen TM Hansen C Martin F Redemann C Yauyoung A Liposomes Containing Synthetic Lipid Derivatives of Poly(Ethylene Glycol) Show Prolonged Circulation Half-Lives Invivo Biochim Biophys Acta 1991 1066 29 36 2065067
11 Gref R Luck M Quellec P Marchand M Dellacherie E Harnisch S 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B Biointerfaces 2000 18 301 13 10915952
12 Iyer AK Khaled G Fang J Maeda H Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discov Today 2006 11 812 8 16935749
13 Nie Y Ji L Ding H Xie L Li L He B Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization Theranostics 2012 2 1092 103 23227125
14 Qhattal HS Hye T Alali A Liu X Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes ACS Nano 2014 8 5423 40 24806526
15 Kirpotin D Park JW Hong K Zalipsky S Li WL Carter P Sterically stabilized Anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro Biochemistry 1997 36 66 75 8993319
16 Yu MK Park J Jon S Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy Theranostics 2012 2 3 44 22272217
17 Sinha R Kim GJ Nie SM Shin DM Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol Cancer Ther 2006 5 1909 17 16928810
18 Ferrari M Cancer nanotechnology: Opportunities and challenges Nat Rev Cancer 2005 5 161 71 15738981
19 Farokhzad OC Langer R Impact of nanotechnology on drug delivery ACS Nano 2009 3 16 20 19206243
20 Stefanick JF Ashley JD Kiziltepe T Bilgicer B A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes ACS Nano 2013 7 2935 47 23421406
21 Khan ZA Chan BM Uniyal S Barbin YP Farhangkhoee H Chen S EDB fibronectin and angiogenesis -- a novel mechanistic pathway Angiogenesis 2005 8 183 96 16308732
22 Chen S Chakrabarti R Keats EC Chen M Chakrabarti S Khan ZA Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells Invest Ophthalmol Vis Sci 2012 53 8333 43 23150625
23 Saw PE Ko YT Jon S Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent Macromol Rapid Commun 2010 31 1155 62 21590869
24 Saw PE Kim S Lee IH Park J Yu M Lee J Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy J Mater Chem B 2013 1 4723 6
25 Park J Kim S Saw PE Lee IH Yu MK Kim M Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging J Control Release 2012 163 111 8 22964395
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.